Conference Coverage
3 months ago
AAOpt 2025: Fitting irregular corneas3 months ago
AAOpt 2025: Heading the frontiers in eye careLatest Content
Advertisement
Shorts
0:50
Crafting your own eyewear brand
a month ago
by
Jordana Joy, Associate Editor
0:37
Why fighting off NEI consolidation matters
4 months ago
by
Jordana Joy, Associate Editor
0:22
The Black EyeCare Perspective on allyship in eye care
4 months ago
by
Jordana Joy, Associate Editor
0:32
How to support patients who are receiving intravitreal injections
4 months ago
by
Jordana Joy, Associate Editor
0:23
Clinical findings of a novel lipid-containing eye drop
4 months ago
by
Jordana Joy, Associate Editor
0:23
Managing neuropathic corneal pain
4 months ago
by
Jordana Joy, Associate Editor
0:21
Catching toxicity in the retina before it is too late
4 months ago
by
Jordana Joy, Associate Editor
Podcasts
Videos
Optometry Times Digital Edition
Utilize oral agents, diet, and glucose monitoring systems when acting to preserve vision.
Knowing what’s on the market for AMD and GA aids in preserving vision.
Telomere biology may link ocular aging and tissue dysfunction in the eye.
Understanding the different expectations between patients with these conditions is key to choosing the appropriate refractive surgery.
Justin Schweitzer, OD, outlines the intricacies of glaucoma care with 3 cases.
RGCs can offer a window into confirming eye condition diagnoses.
Knowing the legal limits of treating family members can ease feelings of obligation.
An effective but underused resource with positive benefits for patients with myopia.
VR technology captures not only visual fields but a full “stack” of pretest results.
Most active ingredients in presbyopia-correcting eye drops, including pilocarpine, aceclidine, and carbachol, are direct-acting cholinergic agonists that activate the iris sphincter muscle, causing pupil constriction.
Continuing Medical Education
All News
Advertisement
Advertisement
The FDA issued a CRL for ONS-5010, citing the need for additional confirmatory efficacy evidence despite previous trials showing efficacy, according to the company.
Edward Choy, partner at Sho Eyeworks, advises practice owners on the fence of developing their own brand to dive in.
Telomere biology may link ocular aging and tissue dysfunction in the eye.
A recent study represents a step forward in investigations of the retinal layers as they are affected by glaucoma.
Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, discuss the company's price points and partner subscription options.
New drugs on the market and survey findings were among some of the top stories in dry eye from the past year.
Understanding the different expectations between patients with these conditions is key to choosing the appropriate refractive surgery.
An overview of the top 10 stories from eye care for 2025.
The researchers conducted a literature search of MEDLINE and Embase, PubMed, Cochrane Library, and Web of Sciences databases from 2003 to 2023.
Edward Choy, partner at Sho Eyeworks, and Diana Canto-Sims, OD, drive home the importance of profitability in creating an eyewear brand.
Advertisement
The PDUFA target action date is June 30, 2026.
Justin Schweitzer, OD, outlines the intricacies of glaucoma care with 3 cases.
The study evaluated thermal dynamics associated with CW-TSCPC and TLT using MicroPulse technology, such as temperature peak, exposure duration, and thermal spread in a simulated ciliary body using computer modeling.
The organization reaffirmed that it stands by myopia defined as a chronic, progression disease.
NCX 470 is Nicox’s lead dual-mechanism bimatoprost eye drop for lowering IOP in open-angle glaucoma or ocular hypertension.
Advertisement
Advertisement